Vaccines /research/taxonomy/term/272/all en Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines /research/article/interdisciplinary-consortium-receives-grant-develop-next-generation-cell-based-cancer-vaccines <p>Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at centralized locations. Saint-Gobain Life Sciences, Kanyr Pharma Inc., the RI-MUHC and ƻԺ have formed a new interdisciplinary consortium to make this technology more accessible. In this project, dendritic cell cancer vaccines will be generated in Saint-Gobain’s VueLife® “C” Series FEP bags.</p> Thu, 22 Dec 2022 22:09:55 +0000 Saint-Gobain Life Sciences 735 at /research